Skip to main content

Table 1 Patients’ characteristics

From: Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors

Cohort n = 34
Age (years)
 Median (range) 61 (22–76)
Gender—n (%)
 Female 14 (41.2)
 Male 20 (58.8)
Karnofsky performance score at diagnosis
 Median 90
Extent of primary resection—n (%)
 Complete 17 (50.0)
 Partial 6 (17.6)
 Open biopsy 11 (32.4)
IDH-mutation status—n (%)
 Wildtype 33 (97.1)
 Mutated 1 (2.9)
MGMT promoter status—n (%)
 Methylated 11 (32.4)
 Non-methylated 6 (17.6)
 Not determined 17 (50.0)
Progression-free survival
 Median (months) 22.4
Overall survival
 Median (months) 35.8
  1. IDH Isocitratdehydrogenase genes 1/2, MGMT 06-Methyl-guanine-methyltransferase gene